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Anchoring of Staphylococcus aureus surface protein to the cell wall is catalyzed by sortase, a
transpeptidase. The contribution of staphylococcal surface proteins to establishment of infection
was examined using a murine septic arthritis model. Intravenous inoculation of mice with the
sortase-deficient mutant S. aureus strain SMK3 did not result in weight loss or severe septic
arthritis, in contrast to the parent strain, S. aureus Newman. Direct inoculation of the sortase
mutant into joint cavities also failed to cause severe synovitis or erosive arthritis. Furthermore,
intravenous inoculation with staphylococci resulted in the rapid clearing of the sortase mutant
from the bloodstream. This phenomenon demonstrates the involvement of host neutrophils;
when these cells were depleted, sortase mutant staphylococci caused severe systemic infection,
although not septic arthritis. These results suggest that sortase mutant staphylococci are signifi-
cantly less virulent than the parent strain, Newman: the sortase mutant has decreased ability to
reach target organs and, once there, to induce an inflammatory response.
Staphylococcus aureus infections in humans are associated
with high morbidity and mortality. The emergence of S. aureus
strains that are resistant to multiple drugs presents a therapeutic
challenge to the use of conventional antibiotics and warrants a
search for novel targets of anti-infective therapy. S. aureus ex-
presses a repertoire of virulence factors, including exotoxins, exo-
enzymes, and adhesins, that contribute to the pathogenesis of
disease [1]. Adhesins, such as fibronectin-, fibrinogen-, vitro-
nectin-, and collagen-binding proteins, are surface proteins that
mediate adherence to the extracellular matrix, which is the first
critical event in the pathogenesis of most infections [2, 3]. During
septic arthritis and osteomyelitis, collagen adhesin and bone sialo-
protein are believed to act as primary virulence factors [4–6].
Furthermore, fibrinogen-binding proteins mediate adherence to
multiple tissues and play a major role in the pathogenesis of sep-
tic arthritis, endocarditis, and other infectious diseases [7–9].
Staphylococcal adhesins are linked to the cell wall by sortase,
an enzyme that cleaves polypeptides at a conserved LPXTG
motif [10–12]. Cell-wall anchoring of surface proteins requires
a C-terminal sorting signal that, in addition to an LPXTG motif,
contains a C-terminal hydrophobic domain and a tail of mostly
positively charged residues [13, 14]. Sorting signals have been
identified in 20 surface proteins of S. aureus [15]. Mutants that
lack the srtA gene appear to be defective in anchoring and dis-
play of many, if not all, surface proteins that bear sorting signals
with an LPXTG motif [16]. Similar sorting signals have been
found in the surface proteins of other gram-positive bacteria, in-
cluding streptococci, clostridia, corynebacteria, lactococci, entero-
cocci, and Listeria [3, 17, 18].
The role of surface proteins in the pathogenesis of bacterial
infections has been studied using S. aureus variants that lack the
srtA gene [16]. When an acute disease model is used, sortase
mutants display a 1.5-log reduction in virulence, compared
with the wild-type Newman strain, and a 2–3-log reduction in
virulence after intravenous inoculation of bacteria, when the
ability of staphylococci to establish kidney infections is measured
[16]. Knockout mutations of the srtA gene in Streptococcus gor-
donii also interfere with cell-wall anchoring and display of surface
proteins, accompanied by a loss of bacterial adhesive properties
[19]. Previous work has left unresolved the question of whether
the sortase-catalyzed transpeptidation reaction is involved in the
pathogenesis of staphylococcal infections other than acute dis-
ease. The aim of the present study was to assess whether sor-
tase-catalyzed anchoring of surface proteins is required for the
establishment of septic arthritis and to ascertain whether sortase
could be a promising future target for therapy.
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Mice. Female NMRI and BALB/c mice, 6–8 weeks old, were
purchased from B&K Universal AB and maintained in the animal
facility of the Department of Rheumatology, University of Go¨te-
borg (Go¨teborg, Sweden). Mice were housed under standard con-
ditions of light and temperature and were fed standard laboratory
chow and water ad libitum.
Bacterial strains. The present study used the human clinical
isolate S. aureus Newman (wild type) [20] and its isogenic sor-
tase-deficient variant, strain SKM3 [16]. SKM3, which carries the
wild-type srtA gene on a plasmid (pSrtA), was used as a control
for trans-complementation [16]. This complemented strain was
only used in the first experiment, because the plasmid did not show
100% stability (stability was 55%–97%). Before inoculation of ani-
mals, staphylococci were cultured for 24 h on tryptic soy agar
(TSA), reinoculated, and grown on TSA for another 24 h. Staphylo-
cocci were then harvested and stored frozen at 220C, after ali-
quots had been suspended in PBS supplemented with 5% bovine
serum albumin and 10% dimethyl sulfoxide. Before inoculation
into mice, staphylococcal suspensions were thawed, and the bacteria
were washed in PBS and then diluted in PBS to achieve the appro-
priate staphylococcal inoculum size. Inocula were injected intrave-
nously into the tail (0.2 mL of staphylococcal suspension) or directly
into the knee cavity (0.02 mL) of mice. To determine the number
of colony-forming units that were injected into animals, aliquots
of staphylococcal suspensions were diluted and plated on TSA,
and colonies were counted.
Animal infections. Four independent in vivo animal experi-
ments and 1 in vitro experiment were performed. NMRI mice
were used in the first 4 experiments and BALB/c mice in the fifth.
First, to evaluate the effect of sortase on the development of hema-
togenous septic arthritis, 3 groups of mice (10 animals in each
group) were inoculated with 6 £ 106 cfu/mouse of S. aureus New-
man, the sortase mutant, or the complemented mutant strain.
Mice were regularly weighed and examined for arthritis until
death or until they were killed (at day 14). Second, to investigate
the effect of sortase expression on the kinetics of S. aureus, 15 mice
were inoculated with 6 £ 106 cfu/mouse of S. aureus Newman, and
another 15 mice were inoculated with the sortase-deficient mutant
strain SKM3. Forty-eight hours after the inoculations, 7 mice in each
group were killed, and culture samples were obtained from blood, kid-
neys, and joints. Blood samples were also obtained from these mice 24
h after inoculation. The remaining mice in each group (7 mice that
were inoculated with the Newman strain and 8 mice that were inocu-
lated with the SKM3 strain) were subjected to bleeding procedure
for bacterial culturing at day 3 and then killed at day 7 after inocu-
lation, at which point samples were obtained from kidneys and joints.
Serum from these mice was used to determine interleukin (IL)–6
levels, a marker for the inflammatory response to staphylococcal in-
fection. During the course of this experiment, 1 mouse that had been
injected with S. aureus Newman died. Third, 6 mice were inoculated
intra-articularly in the left knee joint with 2:4 £ 104 cfu/mouse of S.
aureus Newman, and another 6 mice were inoculated with 2:9 £ 104
cfu/mouse of the SKM3 strain. The contralateral joint was used as
the control and was injected with the same volume of PBS. Animals
were killed 3 days after inoculation, and the joints were examined his-
tologically for signs of inflammation. Fourth, an in vitro phagocytosis
experiment was done to evaluate the role of surface proteins in elimin-
ation of staphylococci. Fifth, to evaluate the role of neutrophils in the
clearance of sortase mutant bacteria, 8 granulocyte-depleted BALB/c
mice and 8 control micewere inoculatedwith the sortase mutant strain.
Infection was clinically evaluated for 1 week, and kidneys were ana-
lyzed for bacteria load.
Clinical evaluation of arthritis. All mice were observed inter-
mittently during the course of these experiments, and limbs were
inspected at regular intervals by a single observer (I.-M.J.) who was
blinded to the clinical parameters for the treatment groups. To
evaluate the intensity of arthritis, a clinical scoring system of 0–3
points for each paw was used (1, mild visible swelling and/or er-
ythema; 2, moderate swelling and erythema; and 3, marked swell-
ing and erythema). The arthritis index was constructed by adding
the scores from all 4 limbs for each animal.
Bacteriologic examination of infected animals. Mice that were
inoculated intravenously with 6 £ 106 cfu of S. aureus were killed
48 h or 7 days after inoculation. Culture samples from blood were
obtained 24 h and 48 h or 3 days and 7 days after bacterial inocu-
lation. The talocrural and radiocarpal joints were dissected asepti-
cally, and culture samples were obtained with cotton sticks and then
cultured on TSA plates containing 5% horse blood for 24 h. All
bacteria loads in the joints that were.104 were set to 104. The kid-
neys were aseptically removed at the time of death, homogenized,
and diluted to appropriate concentrations in PBS. One hundred mi-
croliters of the homogenate was transferred to blood agar plates and
cultured for 24 h, and the colony-forming units were counted. Bac-
teria colonies were tested for catalase and coagulase activity.
Analysis of IL-6. Serum samples from mice participating in the
second in vivo experiment were used to analyze IL-6. The murine
hybridoma cell line B9 is dependent on IL-6 for growth and was
used as an indicator to determine the serum levels of IL-6 [21, 22].
The B9 cells were seeded into microtiter plates (5000 cells/well),
and dilutions of the serum samples were added to each well. After
68 h of incubation, [3H]thymidine (Radiochemical Centre) was
added, and the cells were harvested 6 h later. IL-6–dependent cell
proliferation was measured as the incorporation of [3H]thymidine
by use of liquid scintillation counting and compared with a refer-
ence sample that had been treated with purified recombinant IL-6.
Previous work has shown that the growth of B9 cells is not stimu-
lated by the addition of several recombinant cytokines, including
IL-1a, IL-1b, IL-2, IL-3, IL-5, granulocyte-macrophage colony-
stimulating factor, tumor necrosis factor–a, and interferon-g. Only
a weak stimulation of cell growth was observed when B9 cells were
treated with IL-4 [22].
Histopathologic examination. The knee joints from mice in-
jected intra-articularly with staphylococci were collected at day 3
after the inoculation. Histopathologic examination was performed
after routine paraformaldehyde fixation, decalcification, and paraf-
fin embedding. Tissue sections were stained with hematoxylin and
eosin. The joints were studied by a single blinded examiner (I.-M.J.).
Synovial hypertrophy was defined as a synovial membrane thick-
ness of .2 cell layers [21]. Histologic scoring was used to quanti-
tate the degree of synovial hypertrophy and degradation of cartilage
and/or bone. Scores were set at 1 point for mild, 2 points for mod-
erate, and 3 points for severe synovitis and erosive joint damage
[23].
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Phagocytosis and intracellular killing of bacteria. Replicate
samples from 4 mice were used for a phagocytosis and intracellular
killing assay, using the method of Lissner et al. [24]. In brief, peri-
toneal macrophages were collected by injection of 3 mL of ice-cold
medium (Iscove’s complete medium that contained 100 mg/mL of
gentamicin) into the peritoneal cavity of NMRI mice. After a 1-min
massage of the abdomen, the medium was aspirated, and macrophages
were adjusted to a concentration of 2 £ 106 cells/mL. The cells were
seeded in a volume of 200 mL into 24-well plates (Nunc) and in-
cubated at room temperature for 90 min. Five hundred microliters
of medium was added to each well, and the cells were incubated for
4 h at 37C. The medium then was removed and was replaced by
500 mL of a new, antibiotic-free medium. After incubation overnight
at 37C, the cells were washed in Iscove’s medium and 500 mL of a
suspension with 2 £ 106 cfu/mL of the wild-type S. aureus New-
man strain or the sortase-deficient mutant. After 50 min of incuba-
tion, the cells were washed 3 times to remove nonphagocytosed
bacteria. Macrophages were analyzed for intracellular bacteria con-
tent at 3 different time periods, beginning immediately after incuba-
tion with bacteria and 4 and 24 h later. Gentamicin was added to
cell cultures, and the cultures were incubated for 4 or 24 h to avoid ex-
tracellular replication of bacteria. After the cells were washed in Is-
cove’s medium, the macrophages were lysed by exposure to dis-
tilled water for 20 min. The lysate was diluted 1:1, 1:10, 1:100,
and 1:1000 and plated on 5% horse blood agar plates, and colony-
forming units were counted after overnight incubation.
Neutrophil depletion. Mice were depleted of granulocytes by
intraperitoneal injection of RB6-8C5 antibody, a rat IgG2b that se-
lectively depletes mature mouse neutrophils [25]. Eight BALB/c
mice received 1 mg of the RB6-8C5 antibody, and 8 mice received
the corresponding amount of an IgG rat anti-ovalbumin control anti-
body. Two hours later, the mice were inoculated with 7 £ 106 cfu of
sortase mutant S. aureus. The course of infection was observed for
1 week. After the mice were killed, the kidneys were analyzed for
bacteria load.
Statistical analyses. Statistical evaluations were made using the
Mann-Whitney U test or Fisher’s exact test. All values are reported
as median and interquartile range (IQR). Survival data were ana-
lyzed with the Kaplan-Meier log-rank test.
Results
Role of staphylococcal sortase during the clinical course of
infection. Mice infected with the wild-type S. aureus Newman
strain died from intravenous infections at day 7 (mortality rate,
30%), 10 (mortality rate, 60%), or 14 (mortality rate, 80%) (fig-
ure 1). No lethal infections were observed for mice infected with
the sortase mutant strain SKM3 (P , :01) (figure 1). Mice in-
fected with S. aureus Newman or the SKM3 (pSrtA) strain had
dramatic weight loss, whereas the body weight of mice infected
with the sortase mutant strain SKM3 remained largely unaf-
fected (figure 2). S. aureus Newman, the human clinical isolate
and wild-type strain used in our experiments, caused infectious
arthritis in 50%, 89%, and 100% of infected animals (10 mice/
group) at days 3, 7, and 14 after inoculation, respectively. In con-
trast, the sortase mutant strain SKM3 caused infectious arthritis
in 30% (day 3) and 10% (days 7 and 14, respectively; P , :01 and
P , :05, compared with mice that received the Newman strain)
of the experimental animals. The SKM3 (pSrtA) strain caused an
infectious arthritis in 80% (day 3) and 100% (days 7 and 14) of
all infected animals, which demonstrated that complementation
of the sorting defect restored staphylococcal virulence.
The median arthritis index score (a measure of the severity of
infectious arthritis) for mice infected with S. aureus Newman
increased from 0.5 (IQR, 0–2.0) on day 3 to 2.0 (IQR, 1.0–
4.3) and 2.5 (IQR, 2.0–3.0) on days 7 and 14, respectively. The
sortase mutant strain SKM3 produced median arthritis index
scores of 0 (IQR, 0–1.0) and 0 (IQR, 0–0) during the same time
period (figure 3). Complementation of the sortase mutant pheno-
type restored pathogenicity, and median arthritis index scores of
1.5 (IQR, 1.0–2.0), 3.0 (IQR, 1.0–4.0), and 4.0 (IQR, 2.0–6.0)
were seen on days 3, 7, and 14, respectively. Thus, sortase is
important in the establishment of staphylococcal infectious ar-
thritis. These findings are consistent with the view that staphy-
lococci require adhesion of surface protein to bone and cartilage
tissues to establish a productive infection.
Trans-complementation with plasmid-encoded sortase re-
sulted in weight loss during infection in mice, but this did not
indicate that the virulence defect that prevented strain SKM3
from causing an acute lethal infection had been corrected; only
10% of the SKM3 (pSrtA)–infected animals died (figure 1). These
data suggest that the regulation of sortase expression or a gene-
dosage effect of sortase may play an important role during infection.
Staphylococcal persistence in host tissues. We wondered
whether sortase and sortase-anchored surface proteins are re-
quired for staphylococcal multiplication and survival during in-
fection. Fifteen mice were inoculated with 6 £ 106 cfu/mouse of
S. aureus Newman (wild type), and 15 mice were inoculated
with the sortase-deficient mutant strain SKM3. During the course
Figure 1. Cumulative survival of NMRI mice inoculated with 6 £
106 cfu of Staphylococcus aureus Newman; its isogenic sortase-defi-
cient mutant, strain SKM3; or the sortase mutant complemented with
the wild-type sortase gene on a plasmid (10 mice/group). For mice in-
oculated with S. aureus Newman vs. mice inoculated with the sortase
mutant strain SKM3, P , :01, by the Kaplan-Meier log-rank test.
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of this experiment, 1 mouse that had been injected with S. aureus
Newman died. Figure 4A shows staphylococcal persistence in
blood. One day after injection of 6 £ 106 cfu of S. aureus New-
man, a median level of 770 cfu/mL of blood (IQR, 227–1563
cfu/mL) was found. Wild-type staphylococci persisted in the
blood for 7 days; median levels of 270 cfu/mL (IQR, 170–570
cfu/mL), 20 cfu/mL (IQR, 5–60 cfu/mL), and 63 cfu/mL (IQR,
0–144 cfu/mL) were isolated on days 2, 3, and 7, respectively.
In contrast, the sortase mutant strain SKM3 was almost immedi-
ately cleared from the bloodstream and could be isolated only in
very small amounts from the blood at any time during infection
(figure 4A).
On day 2 after bacterial inoculation, the joints of only 1 of 7
mice infected with the sortase-deficient mutant had bacterial
growth. In contrast, all of the mice inoculated with wild-type
staphylococci displayed bacterial growth in joints (range, 5 to
>104 cfu). On day 7 after bacterial inoculation, 4 of 8 mice in-
oculated with the sortase mutant had bacterial growth in joints,
whereas, again, all of the mice inoculated with wild-type staphy-
lococci showed bacterial growth in joints. In the latter group, the
number of bacteria was very high in many joints (figure 4B).
A similar result was obtained when we analyzed staphylococ-
cal persistence in kidney tissues. S. aureus Newman replicated
to very high numbers during infection: median levels of 7:1£
107cfu (IQR, 1:3 £ 107 to 8:5 £ 107 cfu) and 4:5 £ 107 cfu (IQR,
0:8 £ 107 to 7:6 £ 107 cfu) were found in kidney tissues on days
2 and 7, respectively. Growth of S. aureus SKM3 was reduced:
median levels of 4:6 £ 104 cfu (IQR, 1:0 £ 104 to 11:3 £ 104
cfu) and 4:0 £ 106 cfu (IQR, 0:3 £ 106 to 6:3 £ 106 cfu) were
isolated from the kidneys at the same time points (figure 4C).
These results reveal that sortase and sortase-anchored surface
proteins are required for staphylococcal persistence in the host.
Stimulation of the immune response during staphylococcal
infection. Serum levels of IL-6 were significantly lower in mice
that were infected with the sortase mutant strain than in mice in-
oculated with S. aureus Newman. On day 2 after inoculation,
median IL-6 levels were 950 pg/mL (IQR, 360–1600 pg/mL)
for the sortase mutant strain and 12,800 pg/mL (IQR, 2200–
19,000 pg/mL) for the wild-type strain (figure 5). A large differ-
ence in IL-6 concentrations was also observed on day 7 after
inoculation. These results suggest that infections with wild-type
staphylococci elicit a much more profound inflammatory re-
sponse than do infections with the sortase mutant strain.
Direct arthritogenicity of sortase-expressing staphylococci.
We wondered whether the diminished arthritogenicity of the
sortase mutant strain is due to the increased elimination of sta-
phylococci before they can infect the joint or whether it is
caused by the decreased virulence of staphylococci in situ.
To distinguish between these possibilities, staphylococci were
administered directly into the articular cavity in mice, thereby
bypassing the requirement that intravenously injected staphy-
lococci spread systemically to cause arthritis. Five of 7 mice
that were infected with the wild-type strain Newman showed
moderate to severe synovitis (histologic score >2), whereas
none of the mice infected with the sortase mutant strain dis-
played signs of severe inflammation (P ¼ :02). Indeed, the latter
group showed only a mild synovitis (histologic score<1). More-
over, 4 of the mice injected with the wild-type strain had erosion
of cartilage and/or bone in the knee joints, whereas none of the
mice injected intra-articularly with sortase mutant showed signs
Figure 3. Severity of arthritis in NMRI mice inoculated with 6 £ 106
cfu of Staphylococcus aureus Newman or its isogenic sortase-deficient
mutant, strain SKM3 (10 mice/group). Data shown are median and in-
terquartile range for each group of mice. Comparisons were made using
the Mann-Whitney U test. P values are for the comparison between the
wild-type Newman strain and the sortase mutant strain SKM3. NS, not
significant.
Figure 2. Changes in body weight in NMRI mice inoculated with
6 £ 106 cfu of Staphylococcus aureus Newman; its isogenic sortase-
deficient mutant, strain SKM3; or the sortase mutant complemented
with the wild-type sortase gene on a plasmid (10 mice/group). Data
shown are median and interquartile range for each group of mice. P
values are for the comparison between the wild-type strain Newman
and the sortase mutant strain SKM3.
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of cartilage or bone erosion (P was not significant) (figure 6).
The joints of control mice all had negative results of examina-
tion for inflammation (data not shown).
Phagocytosis and intracellular killing of sortase mutant staphy-
lococci. Because S. aureus SKM3 cannot display surface pro-
teins, we wondered whether sortase mutant staphylococci were
more rapidly phagocytosed and killed than wild-type staphylo-
cocci. To our surprise, no difference in macrophage phagocyto-
sis or killing could be detected between S. aureus Newman and
the sortase mutant strain SKM3 (figure 7).
Effect of neutrophil depletion on infection induced by sortase
mutant S. aureus. Polymorphonuclear neutrophils (PMNs) are
phagocytic cells that represent an important component of the
innate immune response against staphylococcal infection. We
presumed that PMNs play a role in eliminating sortase mutant
staphylococci during infection. Indeed, kidneys from mice de-
Figure 4. Persistence of Staphylococcus aureus in blood (A), early homing of staphylococci to the joints (B), and bacteria load in the kidneys
(C) of NMRI mice inoculated with 6 £ 106 cfu of S. aureus Newman or its isogenic sortase-deficient mutant, strain SKM3 (15 mice/group). Blood
samples were obtained for culture at days 1, 2, 3, and 7 from mice inoculated with the Newman strain (7 mice/time point) and from mice inoculated
with the sortase mutant strain SKM3 (7 or 8 mice/time point). Samples from joints and kidneys were taken after mice were killed, on days 2 and 7.
Data are median and interquartile range for each group of mice. Comparisons were made using the Mann-Whitney U test. NS, not significant.
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pleted of PMNs harbored significantly more staphylococci than
kidneys from mice that received the control antibody (median
level, 12:5 £ 107 cfu [IQR, 0:1 £ 107 to 19:3 £ 107 cfu] vs. 1:8 £
105 cfu [IQR, 0:6 £ 105 to 17:5 £ 105 cfu]; P ¼ :04). One of the
neutrophil-depleted mice died within 1 week of inoculation. The
neutrophil-depleted mice also lost significantly more weight than
did the control mice. On day 3 after staphylococcal inoculation,
the median weight decrease was 16.0% (IQR, 11.5%–21.6%)
for neutrophil-depleted mice, whereas nondepleted control mice
lost only 0.2% of their original weight, with an IQR of 20.9%
to 3.3% (P , :01). One week after the inoculation, the median
weight decrease among neutrophil-depleted mice was even more
pronounced, at 38.8% (IQR, 3.3%–40.9%), whereas nondepleted
control mice had a median weight increase of 0.2% (IQR for
weight change, 24.9% to 3.8%) (P , :05). Only 1 mouse in
each group displayed mild arthritis during the course of the
experiment.
Discussion
The srtA gene product has been shown to be necessary for the
cell-wall anchoring of many surface proteins, and a deletion of
the srtA gene abrogates the display of surface proteins by mutant
S. aureus strains [16]. Because several adhesins, including pro-
tein A, clumping factor, fibronectin-binding proteins, collagen
adhesin, and bone sialoprotein, are considered to be virulence
factors [4, 5, 8, 9, 26, 27], we wondered whether the absence
of all these molecules as a result of inactivation of the sortase
gene would have an impact on staphylococcal virulence in a
murine model of septic arthritis. We report here that mice in-
oculated with the sortase mutant had a significantly higher rate
of survival than mice inoculated with the wild-type parent
strain. Mice infected with the sortase mutant failed to develop
significant histopathologic signs of arthritis. Furthermore, mice
that were inoculated with the sortase mutant did not show signs
of severe infection, as indicated by the absence of a weight de-
crease and by decreased production of inflammatory cytokines,
compared with mice that had been inoculated with the isogenic
wild-type parent strain. Thus, sortase and the sortase-catalyzed
anchoring of surface proteins promote the establishment of mu-
rine septic arthritis and are prerequisites to the development of
severe disease after intravenous injection.
The phenotypic defects of sortase mutants can be explained
in 1 of 2 ways: (1) staphylococci that lack surface proteins
(“naked staphylococci”) may be more rapidly phagocytosed
and killed than are wild-type S. aureus strains, or (2) sortase mu-
tants may be defective in adhering to organ tissues and therefore
cannot colonize target tissues such as bone or cartilage. In an ef-
fort to distinguish between these possibilities, we performed
several experiments. First, after intravenous injection of staphy-
lococci, the sortase mutant strain was much more rapidly cleared
Figure 5. Serum levels of interleukin (IL)–6 after inoculation with
6 £ 106 cfu of Staphylococcus aureus Newman (filled circles) or its
isogenic sortase-deficient mutant, strain SKM3 (open circles) (7 mice/
group at day 2 and 7 or 8 mice/group at day 7). Comparisons were
made using the Mann-Whitney U test. Horizontal bars represent me-
dian values. NS, not significant.
Figure 6. Histopathologic evaluation of knee joints from NMRI
mice 3 days after intra-articular injection with 2:4 £ 104 cfu of Staphy-
lococcus aureus Newman or 2:9 £ 104 cfu of the isogenic sortase-
deficient mutant strain SKM3 (7 mice/group). Histopathologic scores
were used to assess the degree of synovial hypertrophy (circles) and
erosive degradation of cartilage and/or bone (squares). Scores were
set at 1 point for mild, 2 points for moderate, and 3 points for severe
synovitis and erosive joint damage.
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from the bloodstream than was the wild-type parent strain. Sec-
ond, in in vitro phagocytosis experiments used to test whether
the disappearance of staphylococci from blood was caused by
more-rapid phagocytosis, we could detect no differences in
the rate of uptake or killing of the wild-type and the sortase mu-
tant strains by peritoneal macrophages. Although these exper-
iments suggest that macrophages may not be responsible for
the rapid clearing of the sortase mutant strain from the blood
stream, it is also conceivable that macrophage killing requires
blood factors that were absent from our assay. Further work is
needed to address this question. Third, intra-articular injection
of sortase mutant staphylococci into joints failed to produce se-
vere arthritis. Even if the sortase mutant strain was not cleared
from the bloodstream and peripheral tissues, these “naked staphy-
lococci” cannot adhere to target tissues, and they display severe
defects in establishing localized infections. In summary, we think
it is likely that surface proteins of staphylococci contribute to
both the survival (resistance to phagocytic killing) of bacteria in
blood and the adherence of bacteria to organ tissues, mechanisms
that promote localized and generalized S. aureus infections.
Neutrophils play an important role as effector cells in the in-
nate host defense against bacteria and are rapidly recruited to
the site of infection [25]. To analyze the role of PMNs in clearing
sortase mutant staphylococci from the bloodstream, we depleted
this leukocyte population of neutrophils before inoculation of bac-
teria. Neutrophil-depleted mice experienced severe systemic in-
fection after inoculation with the sortase mutant, as indicated by
a dramatic weight loss. In spite of the severe systemic infection,
which presumably was generated by the relatively unhindered
multiplication of sortase mutant staphylococci in blood, the in-
fected animals did not display signs of infectious arthritis. Thus,
the ability of staphylococci to cause arthritis not only is the re-
sult of the survival of bacteria in the tissues but also requires
very specific adherence mechanisms—for example, adherence
mediated by collagen adhesin [4] and clumping factor [28].
In summary, we report that the sortase mutant S. aureus strain
SMK3 is significantly less virulent than its parental strain, S.
aureus Newman. The less severe outcome of infection is due to
the decreased ability of the sortase mutant to reach target organs
and to induce inflammatory response, combined with a more ef-
ficient elimination of the mutant strain by the host innate im-
mune system.
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